Journal article
Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: A meta-analysis
Abstract
Objective: To evaluate the efficacy and safety of rifampicin plus pyrazinamide versus isoniazid for prevention of tuberculosis among persons with or without HIV-infection respectively. Methord: Meta-analysis of randomized controlled trials(RCT) and quasi-randomized controlled trials(quasi RCT) that compared rifampicin plus pyrazinamide for 2-3 months with isoniazid for 6-12 months. Endpoints were development of active tuberculosis, severe …
Authors
Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Lif YP
Journal
Chinese Journal of Evidence Based Medicine, Vol. 7, No. 1, pp. 27–36
Publication Date
January 1, 2007
ISSN
1672-2531